Jane Jaskowiak
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects
- Drug-Induced Adverse Reactions
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Acute Myocardial Infarction Research 3
- Blood Pressure and Hypertension Studies 2
-
- Medication Adherence and Compliance 2
- Co-authors
- Stephen E. Kimmel (5 shared papers)Jesse A. Berlin (4 shared papers)Muredach P. Reilly (3 shared papers)Brian L. Strom (3 shared papers)Jesse Chittams (2 shared papers)Jalpa A. Doshi (2 shared papers)Andrea B. Troxel (3 shared papers)George Loewenstein (1 shared paper)
- Journals
- Journal of the American College of Cardiology (3 papers)Annals of Internal Medicine (1 paper)American Heart Journal (1 paper)Pharmacoepidemiology and Drug Safety (1 paper)PubMed (2 papers)
- Partner nations
- United States
In The Last Decade
Jane Jaskowiak
8 papers receiving 436 citations
Peers
Comparison fields: 5 of 89
- Family Practice 43
- Pharmacology 229
- Cardiology and Cardiovascular Medicine 188
- Biochemistry 41
- General Decision Sciences 10
Countries citing papers authored by Jane Jaskowiak
This map shows the geographic impact of Jane Jaskowiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Jaskowiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Jaskowiak more than expected).
Fields of papers citing papers by Jane Jaskowiak
This network shows the impact of papers produced by Jane Jaskowiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Jaskowiak. The network helps show where Jane Jaskowiak may publish in the future.
Co-authors
The 23 scholars most cited alongside Jane Jaskowiak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 166 | |
| 2 | 2004 | 91 | |
| 3 | 2012 | 86 | |
| 4 | 2001 | 61 | |
| 5 | 2003 | 32 | |
| 6 | A randomized controlled trial of negative co-payments: the CHORD trial. | 2015 | 8 |
| 7 | A randomized controlled trial of co-payment elimination: the CHORD trial. | 2015 | 8 |
| 8 | 2002 | 5 |
About Jane Jaskowiak
Jane Jaskowiak is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice, Economics and Econometrics, Pharmacology and Surgery, having authored 8 papers that have together received 457 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Acute Myocardial Infarction Research (3 papers), Inflammatory mediators and NSAID effects (2 papers), Medication Adherence and Compliance (2 papers), Blood Pressure and Hypertension Studies (2 papers), Healthcare Policy and Management (1 paper) and Smoking Behavior and Cessation (1 paper). The work is most often cited by research in Family Practice (43 citations), Pharmacology (229 citations), Cardiology and Cardiovascular Medicine (188 citations), Biochemistry (41 citations) and General Decision Sciences (10 citations). Jane Jaskowiak has collaborated with scholars based in United States. Frequent co-authors include Stephen E. Kimmel, Jesse A. Berlin, Muredach P. Reilly, Brian L. Strom, Jesse Chittams, Jalpa A. Doshi, Andrea B. Troxel, George Loewenstein, Colleen Brensinger and Kevin G. Volpp. Their work appears in journals such as Journal of the American College of Cardiology, Annals of Internal Medicine, American Heart Journal, Pharmacoepidemiology and Drug Safety and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.